机译:早期检测尿路上膀胱癌患者血浆无细胞DNA超深序的转移复发和治疗疗效监测
Aarhus Univ Hosp Aarhus Denmark;
Aarhus Univ Hosp Aarhus Denmark;
Natera San Carlos CA USA;
Natera San Carlos CA USA;
Natera San Carlos CA USA;
Aarhus Univ Hosp Aarhus Denmark;
Natera San Carlos CA USA;
Aarhus Univ Hosp Aarhus Denmark;
Aarhus Univ Hosp Aarhus Denmark;
Aarhus Univ Hosp Aarhus Denmark;
Aarhus Univ Hosp Aarhus Denmark;
Natera San Carlos CA USA;
Aarhus Univ Hosp Aarhus Denmark;
Natera San Carlos CA USA;
Natera San Carlos CA USA;
Natera San Carlos CA USA;
Natera San Carlos CA USA;
Natera San Carlos CA USA;
Aarhus Univ Hosp Aarhus Denmark;
Natera San Carlos CA USA;
Natera San Carlos CA USA;
Natera San Carlos CA USA;
Natera San Carlos CA USA;
Natera San Carlos CA USA;
Natera San Carlos CA USA;
Natera San Carlos CA USA;
Aarhus Univ Hosp Aarhus Denmark;
Natera San Carlos CA USA;
Natera San Carlos CA USA;
Natera San Carlos CA USA;
Aarhus Univ Hosp Aarhus Denmark;
Natera San Carlos CA USA;
Aarhus Univ Hosp Aarhus Denmark;
Aarhus Univ Hosp Aarhus Denmark;
机译:早期检测尿路上膀胱癌患者血浆无细胞DNA超深序的转移复发和治疗疗效监测
机译:血浆无细胞DNA1定量预测索拉非尼对转移性透明细胞肾细胞癌的治疗效果
机译:使用下一代测序检测转移性乳腺癌患者无细胞血浆DNA中TP53 / PIK3CA突变
机译:冰冷PCR的效用偶联至Sanger测序或下一代测序,用于增加患者监测患者循环自由DNA期间的突变检测敏感性
机译:母体血浆中无细胞DNA的大规模并行测序:生物学分析和临床应用。
机译:血浆无细胞DNA1定量预测索拉非尼对转移性透明细胞肾细胞癌的治疗效果
机译:可重新切除的肺病灶恶性评估和癌症检测通过血浆无细胞DNA靶向基因突变的超深序列